Guan Wei-Jie, Gao Yong-Hua, Xu Gang, Lin Zhi-Ya, Tang Yan, Li Hui-Min, Li Zhi-Min, Zheng Jin-Ping, Chen Rong-Chang, Zhong Nan-Shan
1 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China ; 2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China ; 3 Guangzhou First People's Hospital, Guangzhou 510120, China.
J Thorac Dis. 2015 Apr;7(4):625-36. doi: 10.3978/j.issn.2072-1439.2015.04.04.
Current status of Pseudomonas aeruginosa (PA) infection in clinically stable bronchiectasis in mainland China remains unclear.
To compare the inflammation and lung function impairment in bronchiectasis patients isolated or infected with PA, potentially pathogenic microorganisms (PPMs) and commensals, and to identify factors associated with PA isolation and infection.
Patients with steady-state bronchiectasis and healthy subjects were recruited. Peripheral blood and sputum were sampled to determine inflammatory markers and bacterial loads in steady-state bronchiectasis and health. Spirometry and diffusing capacity were also measured.
We enrolled 144 bronchiectasis patients and 23 healthy subjects. PA isolation and infection accounted for 44 and 39 patients, who demonstrated significant inflammatory responses and markedly impaired spirometry, but not diffusing capacity, compared with healthy subjects and patients isolated with other PPMs and commensals (all P<0.05). Except for heightened sputum inflammatory responses, there were no notable differences in serum inflammation and lung function as with the increased density of PA. Female gender [odds ratio (OR): 3.10 for PA isolation; OR: 3.74 for PA infection], 4 or more exacerbations within 2 years (OR: 3.74 for PA isolation, OR: 2.95 for PA infection) and cystic bronchiectasis (OR: 3.63 for PA isolation, OR: 4.47 for PA infection) were the factors consistently associated with PA isolation and infection.
PA elicits intense inflammation and lung function impairment in steady-state bronchiectasis. The density of PA does not correlate with most clinical indices. PA infection is associated with females, frequent exacerbations and cystic bronchiectasis.
中国大陆临床稳定的支气管扩张症患者中铜绿假单胞菌(PA)感染的现状仍不清楚。
比较支气管扩张症患者中分离出PA、潜在致病微生物(PPM)和共生菌或感染这些病菌后的炎症反应和肺功能损害情况,并确定与PA分离和感染相关的因素。
招募病情稳定的支气管扩张症患者和健康受试者。采集外周血和痰液样本,以确定病情稳定的支气管扩张症患者和健康受试者的炎症标志物和细菌载量。同时测量肺活量和弥散功能。
我们纳入了144例支气管扩张症患者和23名健康受试者。PA分离和感染分别涉及44例和39例患者,与健康受试者以及分离出其他PPM和共生菌的患者相比,这些患者表现出显著的炎症反应,肺活量测定明显受损,但弥散功能未受影响(所有P<0.05)。除痰液炎症反应增强外,血清炎症和肺功能与PA密度增加无显著差异。女性[比值比(OR):PA分离为3.10;PA感染为3.74]、2年内发作4次或更多次(OR:PA分离为3.74,PA感染为2.95)和囊状支气管扩张(OR:PA分离为3.63,PA感染为4.47)是与PA分离和感染始终相关的因素。
PA在病情稳定的支气管扩张症中引发强烈炎症反应和肺功能损害。PA密度与大多数临床指标无关。PA感染与女性、频繁发作和囊状支气管扩张有关。